Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT)

NCT05524311 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators